首页 | 本学科首页   官方微博 | 高级检索  
     

P-糖蛋白在肝细胞癌中的表达及临床研究
引用本文:盖晓东. P-糖蛋白在肝细胞癌中的表达及临床研究[J]. 中国免疫学杂志, 2000, 16(7): 372-374
作者姓名:盖晓东
作者单位:北华大学医学院病理解剖教研室,吉林 132001
基金项目:本课题受吉林省教委基金资助(9850)
摘    要:目的:探讨P-糖蛋白在细胞癌组织中表达及临床意义。方法:采用免疫组化法对72例肝细胞癌,9例正常肝组织进行P-糖蛋白测定,作相关临床因素分析。结果:肝细胞癌组织中P-糖蛋白的阳性表达率为44.0%,正常肝组织表达率为22.0%(P〈0.05)。P-糖蛋白的表达与肝癌的组织分型、分级及预后无明显相关性,并且化疗并不影响P-糖蛋白阳性表达病人的预后。结论:P-糖蛋白在肝细胞癌中的过表达,提示其在肝细胞

关 键 词:肝细胞癌 P-糖蛋白 多药耐药性

Clinical significance of P-glycoprotein expression in hepatocellular carcinoma
CAI Xiao-Dong. Clinical significance of P-glycoprotein expression in hepatocellular carcinoma[J]. Chinese Journal of Immunology, 2000, 16(7): 372-374
Authors:CAI Xiao-Dong
Abstract:Objective: To study the clinical significance of P-glycoprotein(Pgp) expression in hepatocellular carcinoma(HCC). Methods: The expression of P-gp was studied immunohistochemically in 72 HCC and 9 normal liver tissues. Results: The positive rate of P-gp expression in HCC was 44.0%, but only 22.2% in normal liver tissue(P < 0.05) .There was no significance correlation between expression of Pgp and HCC grade, HCC type and prognosis and chemothrapy had no effect on survival time of P-gp positive patients. Conclusion: The authors may come to the conclusion that P-glycoprotein probably plays and improtant role in the poor response of HCC to chemotherapeutic agents .
Keywords:Hepatocellular carcinoma P-glycoprotein Multidrug resistance
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号